WIJITARS

A Critical Review of Modern Biological Techniques in Science Laboratory Technology

Volume 1, Number 1, 2025

Authors

1Gloria Hembafan Tiza; 2Atondo Moses Vershima; 3Precious Nnennaya Akpa-Onyeabor; & 4Abah Moses

Abstract

The rapid evolution of biological laboratory technologies is reshaping the interface between
theoretical knowledge and practical application in science laboratory technology. This
comprehensive literature review synthesizes recent advancements across six interconnected
domains: high-throughput automated sample preparation, CRISPR-based molecular diagnostics,
microfluidic organ-on-a-chip platforms, multi-omics integration, artificial intelligence (AI)-driven
analytical tools, and accelerated evolutionary engineering. Drawing exclusively on peer-reviewed
literature published between 2024 and 2026, this review critically evaluates the technological
innovations transforming contemporary laboratory practice while identifying persistent challenges
in standardization, reproducibility, clinical translation, and workforce preparedness. The analysis
reveals that while automation, miniaturization, and AI integration have significantly enhanced
analytical throughput, precision, and data interpretation capabilities, the translation of these
technologies into routine laboratory workflows remains constrained by infrastructure limitations,
interoperability gaps, and the absence of harmonized quality assurance frameworks. Through
comparative analysis and critical evaluation of the evidence base, this review provides a framework
for understanding the current state of biological laboratory technology and outlines priorities for
future research, education, and policy development.

Keywords

Laboratory automation, CRISPR diagnostics, microfluidics, multi-omics, artificial intelligence, & adaptive laboratory evolution

References

Augustine, R., Al Mamun, A., Hasan, A., Salam, S. A., & Ahmed, R. (2025). Recent advances in
CRISPR-based biosensing technologies for point-of-care diagnostics. Biosensors and
Bioelectronics, 245, 116782.
Chen, H., Zhang, L., Wang, Y., & Liu, X. (2025). Recent progress in high-performance sample
preparation strategies. Journal of Chromatography A, 1762, 466364.
Chen, Y., Li, W., & Zhou, F. (2025). Deep learning for high-content screening: Advances and
challenges in phenotypic drug discovery. Nature Machine Intelligence, 7, 112–125.
Declerck, L., Bouchon, F., Demeester, W., Guidi, C., & De Mey, M. (2026). Accelerated adaptive
laboratory evolution: A tool for evolutionary biotechnology. Biotechnology Advances, 86, 108741.
Li, Y., Wang, J., Chen, S., & Zhao, H. (2026). Recent advances in high-throughput automated
sample preparation technologies in bioanalysis. Talanta, 300, 129171.
Liu, Y., Zhang, W., Chen, X., Li, J., Wang, T., & Zhou, R. (2025). Transformative advances in
single-cell omics: A comprehensive review of foundation models, multimodal integration and
computational ecosystems. Journal of Translational Medicine, 23, 1176.
Mejía-Salazar, J. R., Cruz, K. R., Vásquez, E. M. M., & de Oliveira, O. N. (2020). Microfluidic
point-of-care devices: New trends and future prospects for eHealth diagnostics. Sensors, 20(7),
1951.
More, A. S., Gholap, A. D., & Patil, P. O. (2025). Automation in bioanalysis: A critical review of
current trends and future perspectives. TrAC Trends in Analytical Chemistry, 172, 117589.
Peng, Y., & Lee, E. (2026). Lymphatics-on-a-chip microphysiological system: Engineering
lymphatic structure and function in vitro. Lab on a Chip, 26, 1588–1609.
Pérez Antón, A., Delgado, M., Fernández, R., & Navarro, M. (2024). CRISPR-based SHERLOCK
diagnostics for surveillance of drug-resistant Trypanosoma brucei gambiense. The Lancet Microbe,
5(3), e234–e242.
Poljak, I., Chiappini, C., & Adriani, G. (2026). Engineering perfusion to meet tumor biology: Are
vascularized tumor-on-a-chip models ready to drive therapy innovation? Lab on a Chip, 26,
1162–1190.
Qiu, J., Yang, J., Liu, L., Wen, J., Yang, J., Shi, W., Gao, X., Sun, J., Bai, L., Liu, X., & Gu, Z.
(2026). Engineering organs-on-a-chip via multi-channel microfluidics. Lab on a Chip, 26,
1739–1785.
Sung, J. H., Wang, Y. I., & Shuler, M. L. (2025). Multi-organ-on-a-chip for predictive drug toxicity
screening: Current status and future directions. Advanced Drug Delivery Reviews, 198, 114891.
Wang, L., Chen, Y., Zhang, H., & Liu, J. (2025). Multi-omics strategies for biomarker discovery
and application in personalized oncology. Molecular Biomedicine, 6, 115.
Xu, L., Zhang, Y., & Wang, J. (2024). Amplification-free CRISPR-Cas9 nanopore sequencing for
genomic diagnostics of familial hypercholesterolemia. Nature Communications, 15, 1876.
Yang, S., Li, X., & Chen, Z. (2025). CRISPR/Cas-based biosensing platforms: Current advances
and future perspectives for infectious disease diagnostics. Journal of Infection, 90(2), 106345.
Zhang, H., Liu, Y., & Chen, W. (2026). Artificial intelligence in clinical laboratory diagnostics:
Applications, challenges, and future directions. Clinical Chemistry, 72(1), 45–58.
Zhang, Y., Wang, S., & Li, Z. (2025). Microfluidic sample preparation for single-cell analysis:
Advances and challenges. Microsystems & Nanoengineering, 11, 28.